Oral Parity Update 2013: State Edition

Oral Parity Update 2013: Association of Community Cancer Centers Provides Support
As more oral anti-cancer regimens become the most appropriate form of treatment for cancer patients, the inequality in coverage for oral prescriptions compared with their IV-infused counterparts is becoming clearer. ACCC continues to support oral parity laws in the states, as well as federal legislation.

ACCCBuzz

By Sydney Abbott, JD, Manager, Provider Economics and Public Policy, ACCC

cost disparitiesAs more oral anti-cancer regimens become the most appropriate form of treatment for cancer patients, the inequality in coverage for oral prescriptions compared with their IV-infused counterparts is becoming clearer.  Because health insurance plans cover oral anti-cancer drugs differently than IV chemotherapy and injected anti-cancer medications, patients have to pay far more out-of-pocket for oral drugs than for IV chemotherapy or injected medications. The phrase “oral parity” refers to legislative initiatives intended to protect patients with cancer from the high cost-sharing requirements that are sometimes associated with oral cancer drugs under health insurance plans.

ACCC continues to support oral parity laws in the states, as well as federal legislation.  At the state level, efforts by ACCC members and other organizations are having an impact. So far this year, three additional states have passed parity legislation: Massachusetts, Utah, and now…

View original post 222 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: